KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to $21.8 million.

  • Encompass Health's Gains from Investment Securities rose 131428.57% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 44859.81%. This contributed to the annual value of $21.8 million for FY2024, which is 4695.86% down from last year.
  • Encompass Health's Gains from Investment Securities amounted to $21.8 million in FY2024, which was down 4695.86% from $41.1 million recorded in FY2023.
  • In the past 5 years, Encompass Health's Gains from Investment Securities registered a high of $44.6 million during FY2021, and its lowest value of -$20.3 million during FY2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $21.8 million (2024), whereas its average is $20.4 million.
  • In the last 5 years, Encompass Health's Gains from Investment Securities crashed by 14551.57% in 2022 and then soared by 30246.31% in 2023.
  • Over the past 5 years, Encompass Health's Gains from Investment Securities (Annual) stood at $14.7 million in 2020, then surged by 203.4% to $44.6 million in 2021, then tumbled by 145.52% to -$20.3 million in 2022, then soared by 302.46% to $41.1 million in 2023, then tumbled by 46.96% to $21.8 million in 2024.
  • Its Gains from Investment Securities was $21.8 million in FY2024, compared to $41.1 million in FY2023 and -$20.3 million in FY2022.